| A TLR7-nanoparticle adjuvant promotes a broad immune response against heterologous strains of influenza and SARS-CoV-2 Q Yin, W Luo, V Mallajosyula, Y Bo, J Guo, J Xie, M Sun, R Verma, C Li, ... Nature materials 22 (3), 380-390, 2023 | 41 | 2023 |
| Recent progress in nanomaterials for nucleic acid delivery in cancer immunotherapy Y Mei, R Wang, W Jiang, Y Bo, T Zhang, J Yu, M Cheng, Y Wu, J Cheng, ... Biomaterials science 7 (7), 2640-2651, 2019 | 39 | 2019 |
| In vivo cancer targeting via glycopolyester nanoparticle mediated metabolic cell labeling followed by click reaction H Wang, Y Bo, Y Liu, M Xu, K Cai, R Wang, J Cheng Biomaterials 218, 119305, 2019 | 38 | 2019 |
| “Metaphilic” cell-penetrating polypeptide-vancomycin conjugate efficiently eradicates intracellular bacteria via a dual mechanism Y Jiang, M Han, Y Bo, Y Feng, W Li, JR Wu, Z Song, Z Zhao, Z Tan, ... ACS Central Science 6 (12), 2267-2276, 2020 | 32 | 2020 |
| Biomaterial-Based In Situ Cancer Vaccine Y Bo, H Wang Advanced materials, e2210452, 2023 | 20 | 2023 |
| Metabolic glycan labeling immobilizes dendritic cell membrane and enhances antitumor efficacy of dendritic cell vaccine J Han, R Bhatta, Y Liu, Y Bo, A Elosegui-Artola, H Wang Nature communications 14 (1), 5049, 2023 | 11 | 2023 |
| Targeting infected host cells in vivo via responsive azido-sugar mediated metabolic cell labeling followed by click reaction Y Bo, Y Jiang, K Chen, K Cai, W Li, J Roy, Y Bao, J Cheng Biomaterials 238, 119843, 2020 | 11 | 2020 |
| T cell-responsive macroporous hydrogels for in situ T cell expansion and enhanced antitumor efficacy R Bhatta, J Han, Y Liu, Y Bo, H Wang Biomaterials 293, 121972, 2023 | 10 | 2023 |
| Metabolic tagging of extracellular vesicles and development of enhanced extracellular vesicle based cancer vaccines R Bhatta, J Han, Y Liu, Y Bo, D Lee, J Zhou, Y Wang, ER Nelson, Q Chen, ... Nature communications 14 (1), 8047, 2023 | 7 | 2023 |
| A double crosslinking adhesion mechanism for developing tough hydrogel adhesives J Han, J Park, R Bhatta, Y Liu, Y Bo, J Zhou, H Wang Acta Biomaterialia 150, 199-210, 2022 | 7 | 2022 |
| In Situ Dendritic Cell Recruitment and T Cell Activation for Cancer Immunotherapy J Han, R Bhatta, Y Liu, Y Bo, H Wang Frontiers in Pharmacology 13, 954955, 2022 | 7 | 2022 |
| Materials‐based vaccines for infectious diseases Y Bo, H Wang Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 14 (5 …, 2022 | 5 | 2022 |
| Leveraging intracellular ALDH1A1 activity for selective cancer stem-like cell labeling and targeted treatment via in vivo click reaction Y Bo, J Zhou, K Cai, Y Wang, Y Feng, W Li, Y Jiang, SH Kuo, J Roy, ... Proceedings of the National Academy of Sciences of the United States of …, 2023 | 4 | 2023 |
| Targeted delivery of liposomal chemoimmunotherapy for cancer treatment Y Liu, J Han, Y Bo, R Bhatta, H Wang Frontiers in immunology 13, 1010021, 2022 | 2 | 2022 |
| Nanoengineered polypeptides from tetraphenylethylene-functionalized N-carboxyanhydride: Synthesis, self-assembly and intrinsic aggregation-induced emission X Wang, Z Zhao, T Xue, Z Tan, Z Song, S Wei, Y Bo, Y Wang, J Cheng Progress in Natural Science: Materials International 31 (4), 541-545, 2021 | 2 | 2021 |
| Primary adipocytes as targetable drug depot to prevent post-surgical cancer recurrence Y Bo, Y Wang, J Han, R Bhatta, Y Liu, D Baskaran, J Zhou, H Wang Materials Today Bio 25, 101020, 2024 | | 2024 |
| Selective in vivo metabolic labeling for cell targeting and immune regulation Y Bo University of Illinois at Urbana-Champaign, 2023 | | 2023 |
| A universal TLR7-nanoparticle adjuvant promotes broad immune responses against heterologous strains of Influenza and SARS-CoV-2 Q Yin, W Luo, VVA Mallajosyula, Y Bo, J Guo, J Xie, M Sun, R Verma, ... | | 2021 |
Jianjun ChengChair Professor of Materials Science and Engineering, Westlake University在 westlake.edu.cn 的电子邮件经过验证
Jianjun ChengChair Professor of Materials Science and Engineering, Westlake University在 westlake.edu.cn 的电子邮件经过验证